Financhill
Back

Moderna Quote, Financials, Valuation and Earnings

Moderna Price Quote

$39.44
+0.05 (+-0.3%)
(Updated: December 21, 2024 at 5:37 AM ET)

Moderna Key Stats

Sell
6
Moderna (MRNA) is a Sell

Day range:
$39.12 - $40.83
52-week range:
$35.80 - $170.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.01
P/B ratio:
1.27%

Volume:
35M
Avg. volume:
10.1M
1-year change:
-54.3%
Market cap:
$15.2B
Revenue:
$6.8B
EPS:
$-5.82

How Much Does Moderna Make?

Data Unavailable

Is Moderna Growing As A Company?

Data Unavailable

Moderna Stock Price Performance

  • Did Moderna Stock Go Up Last Month?
    Moderna share price went up by 6.63% last month
  • Did MRNA's Share Price Rise Over The Last Year?
    MRNA share price fell by -54.3% over the past 1 year

What Is Moderna 52-Week High & Low?

  • What Is Moderna’s 52-Week High Share Price?
    Moderna has traded as high as $170.47 over the past 52 weeks
  • What Is Moderna’s 52-Week Low Share Price?
    Moderna has traded as low as $35.80 over the past 52 weeks

Moderna Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Moderna?

Data Unavailable

Is Moderna Cash Flow Positive?

Data Unavailable

Moderna Return On Invested Capital

Data Unavailable

Moderna Earnings Date & Stock Price

  • What Is Moderna's Stock Price Today?
    A single share of MRNA can be purchased today for 39.39
  • What Is Moderna’s Stock Symbol?
    Moderna trades on the nasdaq under the ticker symbol: MRNA
  • When Is Moderna’s Next Earnings Date?
    The next quarterly earnings date for Moderna is scheduled on February 21, 2025
  • When Is MRNA's next ex-dividend date?
    Moderna's next ex-dividend date is December 22, 2024
  • How To Buy Moderna Stock?
    You can buy Moderna shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Moderna Competitors

  • Who Are Moderna's Competitors?
    Below is a list of companies who compete with Moderna or are related in some way:
    • Biogen Inc (BIIB)
    • Eli Lilly and Co (LLY)
    • Merck & Co Inc (MRK)
    • Novavax Inc (NVAX)
    • Pfizer Inc (PFE)

Moderna Dividend Yield

Data Unavailable

Moderna Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 101.55%
Revenue: 3.81% 49.32%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 12
Sell Recommendations: 1
Price Target: 127.09
Upside from Last Price: 222.65%

Major Shareholders

Data Unavailable